Infratentorial neoplasm

Summary

Infratentorial neoplasm (MONDO:0037736) is a cancer and 6 clinical trials. A subtype of brain neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	infratentorial neoplasm
Mondo ID	MONDO:0037736
NCIT	C3139
UMLS	C0021432
MedGen	5803
Is cancer (heuristic)	yes

Also known as: brain neoplasms, infratentorial · infratentorial neoplasm · infratentorial neoplasms · infratentorial tumor · infratentorial tumors · infratentorial tumour · infratentorial tumours · neoplasms, infratentorial

Disease family

This is a subtype of brain neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › brain disorder › brain neoplasm › infratentorial neoplasm

Related subtypes (16): brain cancer, cerebellopontine angle tumor, olfactory nerve neoplasm, cerebellar neoplasm, childhood brain meningioma, olfactory groove meningioma, dysembryoplastic neuroepithelial tumor, hypothalamic neoplasm, optic pathway glioma, choroid plexus neoplasm, brainstem neoplasm, pineal body neoplasm, neoplasm of cerebral hemisphere, benign neoplasm of brain, primary brain neoplasm, optic tract meningioma

Subtypes (1): childhood infratentorial neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	6

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02300766	Not specified	RECRUITING	Cerebellar Mutism Syndrome Study
NCT02933749	Not specified	UNKNOWN	Effects of the Prone and the Sitting Positions on the Brain Oxygenation in Posterior Fossa Surgery
NCT04232059	Not specified	COMPLETED	The Effect of Different Ventilation Strategies on Cerebral Oxygenation Using Near Infrared Spectroscopy (NIRS) in Pediatrics Undergoing Posterior Fossa Tumor Surgery
NCT05192733	Not specified	COMPLETED	PRICE Survey Of Extubation Following Infratentorial Craniotomy
NCT06036732	Not specified	UNKNOWN	A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
NCT06752824	Not specified	COMPLETED	Analgesia Nociception Index (ANI) in Intracranial Surgical Anesthesia